keyword
MENU ▼
Read by QxMD icon Read
search

Transcatheter mitral valve implantation

keyword
https://www.readbyqxmd.com/read/27898502/-full-metal-jacket-treatment-of-multiple-paravalvular-leaks
#1
Giuseppe Santoro, Giancarlo Scognamiglio, Maria T Palladino, Carola Iacono, Giampiero Gaio, Maria G Russo
A 40-year-old man with osteogenesis imperfecta type I submitted to multiple procedures of surgical mitral and aortic valve replacement was referred for refractory congestive heart failure due to significant paravalvular leaks (PVLs) of both mitral and aortic prostheses. Due to perceived very high risk of a further mitroaortic surgery, transcatheter closure of PVLs under three-dimensional echocardiographic guide was performed. Thus, four Amplatzer Vascular Plug type II (St. Jude Medical Corp, St. Paul, Minnesota, USA) devices were implanted into the aortic PVLs, and three Amplatzer Vascular Plug type II devices were used to occlude a huge mitral PVL...
November 24, 2016: Journal of Cardiovascular Medicine
https://www.readbyqxmd.com/read/27892889/the-impact-of-functional-vs-degenerative-mitral-regurgitation-on-clinical-outcomes-among-patients-undergoing-transcatheter-aortic-valve-implantation
#2
René Vollenbroich, Stefan Stortecky, Fabien Praz, Jonas Lanz, Anna Franzone, Katarzyna Zuk, Dik Heg, Marco Valgimigli, Crochan John O'Sullivan, Corinna Heinisch, Eva Roost, Peter Wenaweser, Stephan Windecker, Thomas Pilgrim
BACKGROUND: Among patients undergoing transcatheter aortic valve implantation (TAVI), concomitant mitral regurgitation (MR) has been associated with adverse prognosis. We aimed to assess long-term clinical outcomes according to MR etiology. METHODS: In a single-center registry of consecutive patients undergoing TAVI, we investigated the impact of functional (FMR) vs degenerative (DMR) MR on cardiovascular (CV) mortality throughout 2years of follow-up. RESULTS: Among 603 patients (mean age 82...
October 28, 2016: American Heart Journal
https://www.readbyqxmd.com/read/27876696/stroke-prevention-strategies-in-patients-with-atrial-fibrillation-and-heart-valve-abnormalities-perceptions-of-valvular-atrial-fibrillation-results-of-the-european-heart-rhythm-association-survey
#3
Tatjana S Potpara, Gregory Y H Lip, Torben B Larsen, Antonio Madrid, Dan Dobreanu, Ewa Jędrzejczyk-Patej, Nikolaos Dagres
The purpose of this European Heart Rhythm Association (EHRA) Survey was to assess the perceptions of 'valvular' atrial fibrillation (AF) and management of AF patients with various heart valve abnormalities in daily clinical practice in European electrophysiology (EP) centres. Questionnaire survey was sent via the Internet to the EHRA-EP Research Network Centres. Of the 52 responding centres, 42 (80.8%) were university hospitals. Choosing the most comprehensive definition of valvular AF, a total of 49 centres (94...
October 2016: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/27872440/successful-percutaneous-implantation-of-symetis-acurate-neo-transcatheter-aortic-bioprosthesis-in-a-patient-with-existing-mechanical-mitral-valve
#4
Sina Ali, Yakup Alsancak, Mustafa Duran, Mehmet Bilge
No abstract text is available yet for this article.
November 2016: Anatolian Journal of Cardiology
https://www.readbyqxmd.com/read/27867460/percutaneous-dual-valve-intervention-in-a-high-risk-patient-with-severe-aortic-and-mitral-stenosis
#5
Blaz Mrevlje, Mohamad Aboukura, Christoph A Nienaber
Aortic stenosis is the most frequent and mitral stenosis is the least frequent native single-sided valve disease in Europe. Patients with the combination of severe symptomatic degenerative aortic and mitral stenosis are very rare. Guidelines for the treatment of heart valve diseases are clear for single-valve situations. However, there is no common agreement or recommendation for the best treatment strategy in patients with multiple valve disease and severe concomitant comorbidities. A 76-year-old female patient with the combination of severe degenerative symptomatic aortic and mitral stenosis and several comorbidities including severe obesity, who was found unsuitable surgical candidate by the heart team and unsuitable for two-time general anesthesia in the case of two-step single-valve percutaneous approach by anesthesiologists, underwent successful percutaneous dual-valve single-intervention (transcatheter aortic valve implantation and percutaneous mitral balloon commissurotomy)...
July 2016: Heart Views: the Official Journal of the Gulf Heart Association
https://www.readbyqxmd.com/read/27860182/from-tricuspid-to-double-orifice-morphology-percutaneous-tricuspid-regurgitation-repair-with-the-mitraclip-device-in-congenitally-corrected-transposition-of-great-arteries
#6
Fabien Picard, Victor-Xavier Tadros, Anita W Asgar
Edge to edge transcatheter mitral valve repair with MitraClip (Abbott Vascular, Menlo Park, CA) is increasing for high-risk surgical patients with significant mitral regurgitation. Patients with congenitally corrected transposition of the great arteries (CCTGA) presenting with tricuspid valve regurgitation of a systemic right ventricle may represent particularly challenging candidates for MitraClip given their anatomy. We report the case of a 67-year-old gentleman with CCTGA and severe tricuspid regurgitation who was referred for MitraClip implantation after heart team consensus...
November 10, 2016: Catheterization and Cardiovascular Interventions
https://www.readbyqxmd.com/read/27847071/evolut-r-implantation-to-treat-severe-pure-aortic-regurgitation-in-a-patient-with-mitral-bioprosthesis
#7
Giuseppe Bruschi, Paola Colombo, Stefano Nava, Francesco Musca, Bruno Merlanti, Oriana Belli, Francesco Soriano, Luca Botta, Danile De Caria, Cristina Giannattasio, Claudio F Russo
Transcatheter aortic valves have been designed to treat high-risk surgical candidates affected by severe aortic stenosis, but little is known about the use of transcatheter valves in patients with severe pure aortic regurgitation. We describe the implantation of Medtronic CoreValve Evolut R (Medtronic, Minneapolis, MN) to treat an 82-year-old patient affected by severe pure aortic regurgitation who underwent prior mitral valve replacement with a biological valve protruding into the left ventricular outflow tract...
December 2016: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/27847070/mitraclip-implantation-for-the-treatment-of-new-onset-systolic-anterior-motion-of-the-mitral-valve-after-transcatheter-aortic-valve-replacement
#8
Carmelo Grasso, Salvatore Scandura, Sergio Buccheri, Marco Barbanti, Maria Elena Di Salvo, Sarah Mangiafico, Giuseppe Ronsivalle, Sebastiano Immé, Claudia Tamburino, Martina Patané, Carmelo Sgroi, Davide Capodanno, Piera Capranzano, Corrado Tamburino
New-onset systolic anterior motion of the anterior mitral valve leaflet in patients undergoing transcatheter aortic valve replacement is a rare pathophysiologic mechanism leading to postprocedural development of mitral regurgitation and, eventually, left ventricular outflow obstruction. We report the first human case of successful MitraClip implantation to treat new-onset systolic anterior motion of the mitral valve after transcatheter aortic valve replacement causing severe obstruction to left ventricular outflow that was unresponsive to standard medical therapy...
December 2016: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/27847064/left-ventricular-outflow-tract-obstruction-after-transcatheter-mitral-valve-in-ring-implantation-a-word-of-caution
#9
Sameh M Said, Sorin Pislaru, Kunal D Kotkar, Charanjit S Rihal, William J Mauermann, Hartzell V Schaff, Joseph A Dearani
Left ventricular outflow tract obstruction is a well-known, albeit rare, adverse event that can occur after mitral valve replacement. With the current increase in transcatheter valve interventions, new and unique adverse events may be expected to occur. We present a case of severe left ventricular outflow tract obstruction that developed after transcatheter mitral valve implantation.
December 2016: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/27842946/two-in-one-using-3d-mitral-paravalvular-leak-closure-with-concomitant-transcatheter-valve-in-valve-implantation
#10
Andreas Schuler, Thomas K Jones, Elizabeth Perpetua, Gabriel Aldea, Mark Reisman, G Burkhard Mackensen
No abstract text is available yet for this article.
September 3, 2016: Journal of Cardiothoracic and Vascular Anesthesia
https://www.readbyqxmd.com/read/27829472/post-market-surveillance-to-detect-adverse-events-associated-with-melody%C3%A2-valve-implantation
#11
Kevin D Hill, Bryan H Goldstein, Michael J Angtuaco, Patricia Y Chu, Gregory A Fleming
OBJECTIVE: The aim of this study was to describe previously unrecognised or under-recognised adverse events associated with Melody® valve implantation. BACKGROUND: In rare diseases and conditions, it is typically not feasible to conduct large-scale safety trials before drug or device approval. Therefore, post-market surveillance mechanisms are necessary to detect rare but potentially serious adverse events. METHODS: We reviewed the United States Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database and conducted a structured literature review to evaluate adverse events associated with on- and off-label Melody® valve implantation...
November 10, 2016: Cardiology in the Young
https://www.readbyqxmd.com/read/27816405/atrial-flutter-fibrillation-in-patients-receiving-transcatheter-closure-of-atrial-septal-defect
#12
Shuenn-Nan Chiu, Mei-Hwan Wu, Chia-Ti Tsai, Ling-Ping Lai, Jiunn-Lee Lin, Ming-Tai Lin, Chun-Wei Lu, Jou-Kou Wang
BACKGROUND/PURPOSE: Atrial flutter/fibrillation (AFL/Af) is a common late complication in atrial septal defect (ASD) patients even after occluder implantation. We try to delineate the risk factors of persistent AFL/Af. METHODS: From 1998 to 2010, all patients older than 18 years of age who received ASD occluder implantation in our hospital were enrolled, and their records were retrospectively reviewed. In addition, renin-angiotensin system gene polymorphisms including angiotensinogen gene, A1166C polymorphism on the angiotensin II type I receptor gene, and insertion/deletion (I/D) patterns on the angiotensin-converting enzyme gene were checked using direct sequencing...
November 2, 2016: Journal of the Formosan Medical Association, Taiwan Yi Zhi
https://www.readbyqxmd.com/read/27806986/first-in-human-experience-with-transcatheter-mitral-valve-in-valve-implantation-during-left-ventricular-assist-device-placement
#13
Gabriela Orasanu, Sadeer G Al-Kindi, Monique R Robinson, Guilherme H Oliveira, Mahazarin Ginwalla, Chantal Elamm, Michael Zacharias, Mahmoud Farhoud, Benjamin Medalion, Salil V Deo, Soon J Park, Guilherme F Attizzani, Basar Sareyyupoglu
No abstract text is available yet for this article.
November 2016: Circulation. Heart Failure
https://www.readbyqxmd.com/read/27772601/implantation-of-transcatheter-aortic-prosthesis-in-3-patients-with-mitral-annular-calcification
#14
Heike Baumgarten, John J Squiers, William T Brinkman, J Michael DiMaio, Ambarish Gopal, Michael J Mack, Robert L Smith
Mitral annular calcification (MAC) is a chronic degenerative process at the fibrous base of the mitral valve. It is a feared diagnosis in the context of mitral valve operations because of the risk of severe adverse events such as atrioventricular disruption, injury to the circumflex artery during debridement, and difficult placement of annular sutures. We report a series of 3 consecutive female patients with severe circular MAC who underwent successful mitral valve replacement through a lateral minithoracotomy with use of an inverted transcatheter aortic valve...
November 2016: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/27752761/impact-of-cardiac-comorbidities-on-early-and-1-year-outcome-after-percutaneous-mitral-valve-interventions-data-from-the-german-transcatheter-mitral-valve-interventions-trami-registry
#15
Carsten Schwencke, Klaudija Bijuklic, Taoufik Ouarrak, Edith Lubos, Wolfgang Schillinger, Björn Plicht, Holger Eggebrecht, Stephan Baldus, Gerhard Schymik, Peter Boekstegers, Rainer Hoffmann, Jochen Senges, Joachim Schofer
AIMS: The use of the MitraClip system has gained widespread acceptance for the treatment of patients with mitral regurgitation (MR) who are not suitable for the conventional surgery. This study sought to investigate the early and 1-year outcome after MitraClip therapy of patients with MR and cardiac comorbidities. METHODS AND RESULTS: Outcomes through 12-month follow-up of patients (n = 528) who underwent MitraClip implantation were obtained from the German transcatheter mitral valve interventions (TRAMI) registry...
October 17, 2016: Clinical Research in Cardiology: Official Journal of the German Cardiac Society
https://www.readbyqxmd.com/read/27746060/transapical-transcatheter-mitral-valve-in-valve-implantation-using-an-edwards-sapien-3-valve
#16
Cheng He, Gregory Scalia, Darren L Walters, Andrew Clarke
We describe a successful transcatheter, transapical mitral valve implant within a failed mitral bioprosthesis (valve-in-valve) in a symptomatic 86-year-old patient with prohibitive surgical risks, using the new Sapien 3 balloon-expandable valve. Post-deployment echocardiographic profile of the valve-in-valve was satisfactory and the patient was discharged from hospital uneventfully. This is the first reported case of the Sapien 3 valve used in the mitral valve-in-valve setting.
June 21, 2016: Heart, Lung & Circulation
https://www.readbyqxmd.com/read/27744043/transcatheter-lotus-valve-implantation-in%C3%A2-a-stenotic-mitral-valve
#17
Ben Ren, Zouhair Rahhab, Jan von der Thüsen, Joost Daemen, Marcel L Geleijnse, Peter P T de Jaegere, Arie Pieter Kappetein, Nicolas M Van Mieghem
No abstract text is available yet for this article.
November 14, 2016: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/27678337/surgical-antegrade-transcatheter-mitral-valve-implantation-for-symptomatic-mitral-valve-disease-and-heavily-calcified-annulus
#18
Bettina Langhammer, Christoph Huber, Stephan Windecker, Thierry Carrel
Surgical techniques for the treatment of mitral valve disease (MVD) have continuously evolved; however, anatomical details like severe annular calcification remain challenging and require sophisticated surgical strategies. Among patients with symptomatic MVD referred for surgical valve repair or replacement, four presented with circumferential calcification of the mitral annulus precluding conventional surgical techniques. Successful treatment by implanting a balloon-expandable transcatheter aortic heart valve using an antegrade surgical access was performed...
September 27, 2016: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/27649718/early-endocarditis-and-delayed-left-ventricular-pseudoaneurysm-complicating-a-transapical-transcatheter-mitral-valve-in-valve-implantation-percutaneous-closure-under-local-anesthesia-and-echocardiographic-guidance
#19
Erwan Salaun, Philippe Aldebert, Nicolas Jaussaud, Jean-Charles Spychaj, Laurie Anne Maysou, Frederic Collart, Jean-François Avierinos, Jean-Paul Casalta, Thomas Cuisset, Sandrine Hubert, Marc Lambert, Didier Raoult, Sebastien Renard, Gilbert Habib, Jean-Louis Bonnet
No abstract text is available yet for this article.
October 2016: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/27646067/-imaging-in-structural-heart-disease-impact-on-interventional-therapy
#20
A Schmermund, J Eckert, S N Schelle, H Eggebrecht
For the treatment of structural heart disease, current options in the catheterization laboratory include MitraClip® implantation for treating severe mitral regurgitation, transcatheter aortic valve implantation (TAVI), closure of a patent foramen ovale (PFO) and occlusion of the left atrial appendage (LAA). These treatment options are based on a precise diagnosis provided by modern cardiac imaging, which is indispensable for treatment recommendations. Its importance for supporting the invasive procedures in the catheterization laboratory is less well known...
September 19, 2016: Herz
keyword
keyword
85950
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"